LifeHealthcare Group Limited
(ASX:LHC), one of Australia’s leading independent distributors of high end medical devices today announced its full year results to 30 June 2015.
The Company’s GROWTH STRATEGY continues to deliver strong performance for 2015:
- Revenue up 13.8% to $99.3 million
- Core EBITDA up 14.0% to $17.4 million (Statutory $17.1m)
- Core NPATA up 17.3% to $8.8 million (Statutory $4.3m)
- Core EPS up 17.3% to 20.6 cps (Statutory 10.0 cps)
For further information please download PDF attached:
